相关实验视频
Updated: Jul 13, 2026
09:01
Intraportal Transplantation of Pancreatic Islets in Mouse Model
Published on: May 5, 2018
9.6K
胰腺内自主干细胞治疗1型糖尿病 - 一项实验性研究
1Jawale Hospital, Jalgaon, Maharashtra, India.
Annals of medicine and surgery (2012)
|September 4, 2023
概括
胰腺内干细胞疗法在1型糖尿病患者中显著改善,减少胰岛素需求并改善关键血糖标志物. 这种新的治疗方法为糖尿病管理提供了传统胰岛素注射的有希望的替代方案.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
背景情况:
- 1型糖尿病是一种自身免疫性疾病,胰腺几乎不产生胰岛素,导致高血糖.
- 印度1型糖尿病的发病率为每1000名儿童0.26.
- 目前的治疗依赖于胰岛素注射,疾病修饰的选择有限.
研究的目的:
- 评估1型糖尿病自主胰腺内干细胞治疗的疗效和安全性.
- 为了比较干细胞治疗与常规胰岛素治疗的结果.
主要方法:
- 25名1型糖尿病患者接受了自身的胰腺内干细胞治疗.
- 26名1型糖尿病患者作为接受常规胰岛素治疗的对照组.
- 测量结果包括体重增加,胰岛素需求,C-水平,抗体水平,HbA1c和血糖水平.
主要成果:
- 与对照组相比,干细胞治疗组在统计学上显示出显著的改善.
- 关键的改善包括体重增加,减少胰岛素需求,增加C-水平和降低HbA1c.
- 还观察到抗谷氨酸脱碳酶抗体水平和血糖的显著降低.
结论:
- 自主胰腺内干细胞疗法是一种安全,负担得起,有效的治疗1型糖尿病.
- 这种疗法有可能成为1型糖尿病患者可行的替代治疗选择.
- 与静脉注射相比,直接胰腺内输送干细胞可以提高胰腺度.
相关概念视频
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...